Biocon Biologics a subsidiary of Biocon announced that its subsidiary Biocon Sdn Bhd in Malaysia has been awarded a three-year contract valued at USD 90 million for its recombinant human insulin brand Insugen by the Ministry of Health Malaysia Biocon Sdn Bhd will manufacture and supply its range of insulins to its partners Duopharma Marketing Sdn Bhd a subsidiary of Duopharma Biotech a leading pharmaceutical and biotech company in Malaysia Biocon Biologics Insugen formulations will be available to patients at all Ministry of Health hospitals district health offices and health clinics
Related Tags
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.